Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Apr 29.
Published in final edited form as: Eur Biophys J. 2011 Jun 28;40(11):1259–1270. doi: 10.1007/s00249-011-0713-4

Zinc modulates copper coordination mode in prion protein octa-repeat subdomains

Francesco Stellato 1,2, Ann Spevacek 3, Olivier Proux 4, Velia Minicozzi 5, Glenn Millhauser 6, Silvia Morante 7,
PMCID: PMC4850921  NIHMSID: NIHMS778285  PMID: 21710304

Abstract

In this work we present and analyse XAS measurements carried out on various portions of Prion-protein tetra-octa-repeat peptides in complexes with Cu(II) ions, both in the presence and in the absence of Zn(II). Because of the ability of the XAS technique to provide detailed local structural information, we are able to demonstrate that Zn acts by directly interacting with the peptide, in this way competing with Cu for binding with histidine. This finding suggests that metal binding competition can be important in the more general context of metal homeostasis.

Keywords: Prion protein, Zinc, Copper, XAS spectroscopy, Metal homeostasis

Introduction

Transmissible spongiform encephalopathies (TSE), also known as Prion diseases, belong to a broad class of diseases including pathologies that can affect different species. Among these diseases we find Creutzfeldt–Jakob disease in humans, scrapie in sheep (from which the generic name for the misfolded form of the Prion protein is taken), and bovine spongiform encephalopathy (or BSE) in cattle.

There is increasing experimental evidence that in all TSEs the occurrence of an abnormal form of a protein called a Prion (shorthand for proteinaceous infectious particle; Prusiner 1998) protein (PrP) is of crucial importance. PrP is a membrane protein that is anchored to the membrane surface via a glycosyl phosphatidyl inositol group. It occurs in two alternative conformers: the cellular native harmless conformer, PrPC, rich in α-helix, and the aberrant pathogenic conformer, PrPSc (or scrapie PrP) that has self-replicating properties and is characterized by larger β-sheet content (Gasset et al. 1993; Pan et al. 1993; Morante 2008).

The structure of the C-terminal domain of PrPC has been solved by both NMR (Dominikus et al. 2005) and X-ray diffraction (Burns et al. 2002) techniques, whereas the only available structural information about PrPSc is on its secondary structure (Eghiaian et al. 2004). The unstructured N-terminal region of mammalian PrP is characterized by a highly conserved domain consisting of a variable number (from four to six depending on the species) of tandem repeats of eight amino acid residues (PHGGGWGQ) termed octa-repeat.

Although the structural changes characteristic of the switch between the two conformers occur in the C-terminal domain, the N-terminal region seems to have a physiological function in subcellular trafficking (Nunziante et al. 2003). Among the different functions already tentatively attributed to PrPC, Cu2+ binding is the only one that has been correlated with the physiological impairments linked to TSE (Stockel et al. 1998; Rachidi et al. 2003). The main Cu2+ binding site has been located within the octa-repeat region by use of several different experimental techniques (Hornshaw et al. 1995; Whittal et al. 2000; Burns et al. 2002; Qin et al. 2002; Wells et al. 2006). Other Cu2+ binding sites have been identified in the C-terminal globular domain (Hasnain et al. 2001; Cereghetti et al. 2001; Burns et al. 2003). Studies with PrPC models in the form of synthetic and recombinant pep-tides have shown binding stoichiometries of up to one Cu2+ per octa-repeat group.

In previous work (Morante et al. 2004) X-ray absorption spectroscopy (XAS) was used to explore the Cu2+ site geometry in PrP peptides containing one, two, and four octa-repeats and in the whole recombinant form of bovine PrP (BoPrP). In that paper a model was proposed in which the Cu2+ coordination mode depends on the [Cu2+]:[octa-repeat] concentration ratio. The model is in good agreement with the EPR results of Chattopadhyay et al. (2005), in which it is shown that Cu2+ can be found in three different coordination modes, called “components”, whose relative abundance also depends on the [Cu2+]:[octa-repeat] concentration ratio.

In particular, the geometry of the component 1 metal site is seen to be characterized by the same structure visible in the crystal (Burns et al. 2002), where the metal binding site appears to be located within the octa-repeat subsegment HGGGW. Component 2 binding is observed only in PrP structures containing two or more octa-repeat segments and EPR data have shown that there His acts as a bidentate ligand, thus giving rise to a 2N2O Cu2+ coordination. Component 3 coordination is, instead, observed only in tri and tetra-octa-repeat structures at low Cu2+ concentration (< 1.0 equiv.) suggesting that it only occurs if three or four sequential HGGGW segments (or in other words three or four (neutral) imidazole rings) are available.

More recently, new EPR measurements carried out by the same group (Walter et al. 2007) have shown that the presence of Zn2+ modulates mode of the Cu2+ binding to the synthetic PrP tetra-octa-repeat peptide. In particular it has been suggested that, even if Zn2+ is not able to completely remove Cu2+, increasing the Zn2+ concentration can progressively change the way Cu2+ is bound to the tetra-octa-repeat. This modification has been interpreted in terms of variation of the relative amount of each of the three components. The question that cannot be answered by EPR experiments is by which mechanism Zn2+ affects Cu2+ binding.

In the work discussed in this paper we exploited the possibility offered by XAS spectroscopy of directly and separately looking at the structure around both Cu2+ and Zn2+ ions when they are simultaneously present in the sample, thus overcoming the intrinsic limitation of Zn2+ being EPR silent.

Experimental procedures

XAS experiments

XAS experiments on the Cu and Zn K-edges of PrP-octa-repeat samples were performed at the BM30B beamline of the European Synchrotron Radiation Facility (Grenoble, France) (Proux et al. 2005). The storage ring was operating in 16 bunches mode at 6 GeV with a ~90 mA current. The beam energy was selected using an Si(220) double-crystal monochromator with an experimental resolution close to that theoretically predicted (namely ~ 0.5 eV) (Proux et al. 2006). The beam spot on the sample was approximately 300 × 200 µm2 (H × V, FWHM). Because of the low Cu2+ and Zn2+ concentrations, spectra were recorded in fluorescence mode using a 30-element solid-state Ge detector. To avoid photo-degradation and spectra evolution during XAS measurements, all the samples were cooled to 13 K (−260°C) by use of a liquid helium cryostat. To prevent Cu photo-reduction samples are moved at each scan in order for the radiation not to hit the same portion of the sample.

The energy range of Zn K-edge spectra is shortened by the need to avoid effects on Zn Kα fluorescence of the Cu Kβ fluorescence line contribution.

XAS data analysis

For each sample the several collected spectra were first averaged and then normalized using ATHENA software (Ravel and Newville 2005). This normalization procedure is necessary to enable quantitative comparison of the X-ray absorption near edge structure (XANES) regions among different samples. ATHENA is also used to extract the χ(k) signal1 in the extended X-ray absorption fine structure (EXAFS) region. The χ(k) data are fitted by use of the EXCURV98 package (Binsted 1998) and structural information is extracted. The theoretical expression of χ(k) is calculated by taking into account single and multiple scattering contributions (Fonda 1992). The so-called constrained refinement strategy, which consists in treating each amino acid residue as a rigid body, is used. This enables reduction of the number of free variables characterizing the structural models taken into consideration in the analysis (Binsted et al. 1992).2

Sample preparation

Synthetic PrP octa-repeat peptides were prepared using the fluorenylmethoxycarbonyl (Fmoc) method, as previously described by Burns et al. (2002) and Aronoff-Spencer et al. (2000). The amino acid sequence of the synthetic peptide was: Ac-KKRPKPWGQ(PHGGGWGQ)4-NH2.

The initial nine amino acid residues, preceding the four consecutive octa-repeat groups present in the N-terminal of natural PrP, were inserted to increase peptide solubility. The peptide was, as usual, acetylated at the N-terminus and amidated at the C-terminus to mimic the presence of the missing portion of the natural protein. All samples were prepared by dissolving the peptide in degassed solvent containing 25 mM N-ethylmorpholine (NEM) buffer and 20% (v/v) glycerol at pH 7.4. The peptide concentration used for XAS samples was 0.2 mM. Cu2+ and Zn2+ were added as the salts CuSO4 and ZnCl2, respectively. As shown in Table 1, two classes of sample were prepared and measured: samples Si (i = 1, 2, 3) prepared in the absence of Zn2+, and samples Si_Zn (i = 1, 2, 3), prepared in the presence of Zn2+. The corresponding two buffers were also measured. In Table 1 the Cu2+ concentrations of the measured samples, expressed in mM (column 2) or in equivalents (column 4), are reported. In column 5 we specify the metal at the K-edge of which measurements had been performed. We performed 11 (i.e. 9 plus 2 for buffers) sets of measurements. In the last two columns we also list the approximate Cu2+ binding component percentage, extracted from EPR measurements (Walter et al. 2007). As already suggested by Walter et al. (2007), we group components 1 and 2, which for short we call component α. For uniformity of notation we then denote component 3 by β.

Table 1.

List of measured samples

Sample [Cu2+] (mM) [Zn2+] (mM) Cu2+ bound (eq.) Edge Cα (%) Cβ (%)
S1 0.16 0 0.8 Cu 0 100
S2 0.4 0 2 Cu 80 20
S3 0.6 0 3 Cu 100 0
S1_Zn 0.16 0.6 0.8 Cu, Zn 55 45
S2_Zn 0.4 0.6 2 Cu, Zn 85 15
S3_Zn 0.6 0.6 3 Cu, Zn 100 0
B_Cu 2.0 0 Cu
B_Zn 0 2.0 Zn

For each sample (column 1) the concentration of Cu2+ in mM and equivalents (columns 2 and 4) and of Zn2+ in mM (column 3) is given. In column 5 the edge at which each spectrum has been collected is reported. In the last two columns we give the percentage of α and β components (see text) as obtained from Fig. 1

Results

Figure 1, where we summarize the EPR results already presented by Walter et al. (2007), clearly shows that the mode of Cu2+ coordination is indeed modified by the presence of Zn2+. In particular it is seen that the effect of Zn2+ is stronger at moderate Cu2+ concentrations and tends to disappear at high Cu2+ concentration. At moderate Cu2+ concentrations, where Zn2+ is more effective, the presence of Zn2+ induces an increase of the α component, thus pushing the system toward Cu2+ binding modes in which the number of bound His units is lower.

Fig. 1.

Fig. 1

Plot of α (red) and β (black) component concentrations versus Cu2+ concentration. Full lines are in the absence and dotted lines in the presence of Zn2+. The three blue vertical lines are drawn to indicate the three Cu2+ concentrations at which XAS data were collected (Table 1). Concentrations are given both in mM (right and top axes) and in equivalents (left and bottom axes)

XAS technique has the potential to (dis)prove this mechanism because, at variance with EPR, it enables direct investigation of the atomic environment of Zn2+. In particular we want to discriminate between the situation in which Zn2+ affects the Cu2+ binding mode by directly binding to the peptide and the situation in which, by some more complicated and indirect mechanism, Zn2+ induces structural peptide modifications that in turn affect the geometry of the Cu2+-binding site. With the purpose of investigating these features we acquired XAS spectra of samples with different Cu2+ concentrations in the absence and in the presence of Zn2+ at the Cu and Zn K-edges.

Starting with a 0.2 mM tetra-octa-repeat solution which yields a histidine concentration [His] = 0.8 mM, we prepared three samples containing Cu2+ at 0.16, 0.4 and 0.6 mM, corresponding to 0.8, 2 and 3 equivalents (= [Cu2+]/[pept]), respectively (Table 1; Fig. 1).

Each solution was further subdivided into two sub-samples and 0.6 mM Zn2+ was added to one of these. The two reference buffer solutions were prepared as described above.

To gain an initial understanding of the structural properties of the metal (Zn2+ and Cu2+) coordination modes, we started by examining gross similarities and differences among the many spectra we measured. For this purpose we first compared the XANES and/or EXAFS regions of the spectra qualitatively but systematically.

Qualitative XAS data analysis

From Fig. 2 it is immediately evident from the shape of the feature at the top of the sharply rising part of the spectrum (called “white line”) that the spectrum of Cu2+ in buffer is significantly different from that of Cu2+ bound to the peptide at all the Cu2+ concentrations at which data were acquired.

Fig. 2.

Fig. 2

Comparison among XANES spectra taken at the Cu K-edge of the three samples prepared at the three different Cu2+ concentrations of Table 1, in the absence of Zn2+, namely S1 (black), S2 (blue), S3 (green). The spectrum of the B_Cu buffer (red) is also shown. Here µ(E) is the normalized absorption coefficient2

In Fig. 3, the same type of comparison as in Fig. 2, but referred to the EXAFS region, is displayed. As usual, in order to partly compensate for the rapid signal decrease with increasing k, the experimental data have been multiplied by k3. Because of the very low Cu2+ concentration in sample S1, the corresponding spectrum (black line) appears to be rather noisy. Nevertheless, fixing our attention on the low-k part of the EXAFS spectrum, where noise is under control, we can observe that again the Cu-buffer (B_Cu) spectrum is markedly different from that of all the other samples, whereas the S2 and S3 spectra are very similar but substantially different from that of S1. By focussing on the appearance of a double peak in the wave number region between k ≈ 3.5 Å−1 and k ≈ 4.5 Å−1, which is a fingerprint feature for the presence of bound histidine residues (Ferreira et al. 2002), we can conclude that their number decreases going from S1 to S3, and it is obviously zero in B_Cu.

Fig. 3.

Fig. 3

The same comparison as in Fig. 2 for the EXAFS region. Colours are as in Fig. 2

This qualitative behaviour is the same as that observed in EPR experiments (Walter et al. 2007). In fact, at low Cu2+ concentration (sample S1) only the β component is present, and its fraction decreases with increasing Cu2+ concentration. Indeed, the fraction of β component is already very low at 2 Cu2+ equivalents (sample S2) and completely disappears at 3 Cu2+ equivalents (sample S3), as seen in Fig. 1.

The same type of analysis was then performed by comparing the spectra taken at the Zn K-edge at the three different Cu2+ concentrations (samples Si_Zn in Table 1). Now the reference spectrum is that of the Zn–buffer sample (B_Zn). Looking at the XANES region (Fig. 4), one can conclude that, at least for sample S1_Zn, a significant amount of Zn2+ must be bound to the peptide, because its spectrum shows general features substantially different from that of the B_Zn sample.

Fig. 4.

Fig. 4

Comparison among XANES spectra taken at the Zn K-edge of the three samples prepared at the three different Cu2+ concentrations of Table 1, in the presence of Zn2+, namely S1_Zn (black), S2_Zn (blue), S3_Zn (green). The spectrum of the B_Zn buffer (red) is also shown

The same qualitative conclusions can be drawn by studying the EXAFS part of these spectra, shown in Fig. 5. Indeed the general spectral features of S1_Zn (which is the sample at the lowest Cu2+ concentration) are substantially different from those of Zn2+ in buffer, whereas the spectra of the samples in which the Cu2+ concentration is higher (S2_Zn and S3_Zn) are almost identical to each other and very similar to the spectrum of Zn2+ in buffer. In other words, the local Zn2+ environment in the S1_Zn sample is significantly different from that of Zn2+ in solution, thus proving that at least some of the Zn2+ is bound to the peptide.

Fig. 5.

Fig. 5

Same comparison as in Fig. 4 for the EXAFS region

Finally, in order to better display the effect of Zn2+ on the Cu2+ coordination geometry, the EXAFS spectra of Si and Si_Zn samples are compared pair-wise in Fig. 6, focussing attention on the low-k region of the spectrum in which the data are statistically more accurate. The comparison confirms that only in sample S1 is the mode of Cu2+ coordination substantially affected by the presence of Zn2+.

Fig. 6.

Fig. 6

Pair-wise comparison between samples in the absence, Si, and in the presence, Si_Zn, of Zn, in the low-k region of the EXAFS spectrum at the Cu K-edge

Quantitative XAS data analysis

The qualitative analysis presented in the previous sections has led to two main conclusions:

  1. the presence of Zn2+ does affect the mode of Cu2+ coordination, and

  2. Zn2+ is able to bind to the PrP-octa-repeat domain by partially displacing Cu2+.

In this section we want to make the second of these statements more quantitative and precise by trying to structurally characterize the Zn2+ binding site environment. This is done by fitting the EXAFS data at the Zn K-edge to appropriate atomic model structures.

Measurements at the Cu K-edge are not really useful for this discussion because the only sets of data in which the EXAFS signal-to-noise ratio is sufficiently good (i.e. those corresponding to samples S3 and S3_Zn) do not appear to be in any appreciable way affected by the presence of Zn2+. This conclusion also follows from the EPR data of Fig. 1, in which it is clearly apparent that at this high Cu2+ concentration the solid lines (EPR data in the presence of Zn2+) tend to coincide with the broken lines (EPR data in the absence of Zn2+).3

We shall, then, concentrate on data at the Zn K-edge, and in particular for sample S1_Zn, for which the effect of the presence of Zn2+ on the Cu2+ coordination mode looks more pronounced (compare solid and broken curves in Fig. 1). Our objective is to extract from the XAS data the important Zn2+-related structural information that is not directly available from EPR.

To proceed to quantitative analysis, we make the assumption that the Zn2+ can be present in our samples in two different structural configurations, one corresponding to Zn2+ in solution (complexed as in the buffer sample B_Zn) and the second corresponding to Zn2+ directly bound to the peptide. At this point, because the geometrical information that one can extract from the XAS data is the result of an average of the signals from all the structural Zn2+ environments, we need an estimate of the relative weight of these two Zn2+ coordination modes.

At a given the total His concentration, [His]tot, the His fraction available for Zn2+ coordination, [His]av, is:

[His]av=[His]tot[His]Cu (1)

where [His]Cu is the His fraction that is already engaged in Cu2+ binding. To estimate [His]Cu in Eq. (1), we can exploit the EPR results of Chattopadhyay et al. (2005). EPR data show, in fact, that, in the presence of Zn2+ and at 0.8 Cu2+ equivalents (sample S1_Zn), approximately 45% of Cu2+ is found in component β4 and the remaining 55% in component α (Fig. 1), and no Cu2+ is found free in solution.5 In other words, all Cu2+ ions are involved in some kind of peptide binding because none can be fully substituted by Zn2+. This implies that the amount of His bound to Cu2+ can be estimated by use of the formula:

[His]Cu=(0.45×4+0.55×1)×0.16 mM=0.38 mM, (2)

where the numbers 0.45 and 0.55 are the fractions of Cu2+ in the β and α components, respectively, and 0.16 mM is the Cu2+ concentration in sample S1_Zn; the integers 4 and 1 are the numbers of His units bound to the Cu2+ in the β and α components, respectively.

Because, according to our assumption, the total amount of Zn2+ in the sample, [Zn2+]tot, is distributed between Zn2+ bound to the peptide, [Zn2+]His, and Zn2+ free in solution, [Zn2+]buffer,6 in the context of our two-component model, we obtain:

[Zn2+]tot=[Zn2+]His+[Zn2+]buffer (3)

We also assume for simplicity that for each sample the number of His residues bound to Zn2+ is homogenous. We are thus led to consider four possible models, Mn, according to the number n (=1, 2, 3, and 4) of His residues bound to Zn2+. With the above simplifying assumptions we obtain:

[Zn2+]Hisn=[His]avn (4)

where n is the number of His units supposed to be bound to Zn2+. At this point, by use of Eq. (1), we finally obtain:

[His]av=[His]tot[His]Cu=(0.80.38) mM=0.42 mM (5)

In Table 2 we have reported the concentrations of Zn2+ bound to His (column 3) together with the corresponding concentration of Zn2+ in the buffer (column 4) for each of the four models considered (column 1), computed using Eqs. (1)(4).

Table 2.

List of proposed Zn2+ coordination models (column 1) with n the number of Zn2+ bound His’s (column 2)

Two-component
model
n [Zn2+]His (in %) [Zn2+]buffer (in %)
M1 1 0.42 mM (70) 0.18 mM (30)
M2 2 0.21 mM (35) 0.39 mM (65)
M3 3 0.14 mM (23) 0.46 mM (77)
M4 4 0.11 mM (18) 0.49 mM (82)

Columns 3 and 4 report the Zn2+ concentrations (in %) bound to His units, [Zn2+]His, and free in solution, [Zn2+]buffer, respectively

To check the validity of this two-component model, we must first obtain reliable structural information about the atomic environment of Zn2+ in buffer. The best fit of the EXAFS B_Zn data is shown in Fig. 7 and is obtained by assuming Zn2+ is coordinated to six oxygen atoms located at a distance of 2.07 Å in octahedral geometry, as expected on the basis of, for instance, the results of D’Angelo et al. (2002a, b).

Fig. 7.

Fig. 7

Best fit of the EXAFS Zn2+ buffer spectrum (upper panel). Experimental data are in black and the best-fit curve is in grey. The amplitude of the corresponding FT spectra is shown in the lower panel

As for the S1_Zn EXAFS spectrum, four different fits (Fig. 8) have been performed according to the number of His units assumed to be bound to Zn2+. The fraction of Zn2+ that remains free in solution in each case can be found in Table 2.

Fig. 8.

Fig. 8

Comparison between experimental XAS spectra of sample S1_Zn at the Zn K-edge (black) and the simulated spectra (grey) corresponding to the four models of Table 2. EXAFS data are shown in the left column. The amplitudes of the corresponding FT spectra are displayed in the right column

It is rather clear from Fig. 8 that by increasing the number of His units supposedly bound to a single Zn2+ ion (i.e. moving from model M1 to model M4) and thus correspondingly increasing the fraction of Zn2+ in solution (Table 2), the quality of the fit (quantified in terms of the standard quality factor, R7) significantly deteriorates.8 In particular, R seems to be unacceptably high for models M3 and M4 (49 and 60%, respectively). In contrast, it decreases to rather good values, 34 and 35%, for models M1 and M2.

The net outcome of the analysis is that there are qualitative and quantitative reasons to discard models M3 and M4 as unphysical, and, although we do not have enough “resolution” to choose between models M1 and M2, they seem to yield a quite accurate description of the Zn2+ structural environment.9

We end by noting that in the Fourier transform (FT) of the simulated spectra the peak at approximately 3 Å (which is a fingerprint of the presence of histidine and is expected to become increasingly intense with the number of bound histidines (Strange et al. 1990)) is not visible in our case, because, as we explained above, in the situation in which more histidines are bound to Zn2+, more Zn2+ is found in solution (Table 2). Indeed, because the simulated XAS spectrum is the result of the sum of the features coming from all possible Zn2+ coordination modes, the histidine peak is either too small (when only one histidine is bound) or obscured by the superimposed contribution coming from Zn2+ in buffer (when a larger number of histidines is bound).

Fourier transform and BVS analysis

Further information about the structure of the Zn2+ binding site, confirming our previous results, can be extracted by using the FT of the XAS spectra obtained from sample Si_Zn (i = 1, 2, 3) to set up a bond valence sum (BVS) analysis (Brown and Altermatt 1985).

Assuming the validity of the two-component model described above, we expect the location, riFT, of the main peak in the |FT| (i.e. the mean distance of the first shell atoms from the metal), to be given by the formula:

riFT=xin×6×rbuffer+(1xin)×4rinxin×6+(1xin)×4 (6)

in which the ratio:

xin=[Zn2+]bufferin[Zn2+]total (7)

represents the fraction of Zn2+ free in solution in the three Si_Zn (i = 1, 2, 3) samples expected for the four models Mn (n = 1, 2, 3, 4). The quantity [Zn2+]bufferin is computed by use of Eqs. (3) and (4) and hence depends on the sample and the model. In Eq. (6)rbuffer〉 is the Zn2+ first shell mean distance of the (xin fraction of) Zn2+ that is free in solution. From the fit to the XAS data we find 〈rbuffer〉 = 2.07. Finally 〈rin〉 is the Zn2+ first shell mean distance of the remaining (1 – xin) Zn2+ fraction bound to the peptide and represents the unknown quantity we ought to determine in the different situations under study. The coordination number is taken to be 6 for Zn2+ in solution and 4 for Zn2+ bound to the peptide.

In Table 3 the quantities appearing in Eq. (6) for all the samples (column 1), i = 1, 2, 3, and all the models (column 2), n = 1, 2, 3, 4, are reported. The first shell mean distance, riFT (column 3), is obtained by first shell Fourier filtered data fitting in which four oxygen Zn2+ coordination is assumed. The values of 〈rin〉, obtained solving Eq. (6), are reported in column 5.

Table 3.

Summary of the results from analysis of the four proposed Zn2+ coordination models, Mn

Sample Model ri〉(Å) xin rin〉(Å) (BVS)in
S1_Zn M1 2.026 ± 0.009 0.30 1.99 ± 0.02 1.88 ± 0.08
M2 0.65 1.89 ± 0.03 2.5 ± 0.3
M3 0.77 1.78 ± 0.05 3.3 ± 0.5
M4 0.82 1.67 ± 0.07 4.6 ± 0.9
S2_Zn M1 2.051 ± 0.007 0.58 2.00 ± 0.02 1.8 ± 0.1
M2 0.79 1.92 ± 0.04 2.3 ± 0.4
M3 0.86 1.83 ± 0.07 2.9 ± 0.5
M4 0.90 1.7 ± 0.1 4 ± 1
S3_Zn M1 2.075 ± 0.007 0.67 2.08 ± 0.03 1.5 ± 0.1
M2 0.83 2.08 ± 0.05 1.5 ± 0.2
M3 0.89 2.08 ± 0.09 1.5 ± 0.4
M4 0.92 2.1 ± 0.1 1.5 ± 0.5
Buffer 2.075 ± 0.005 2.2 ± 0.2

Column 1 shows the measured samples, column 2 the proposed model, column 3 the fraction of Zn2+ in buffer (from Eq. (7)), column 4 the mean first shell distance (computed from Eq. (6)), column 5 the (BVS) values computed from Eq. (9)

With this information available a possible means of choosing among the different metal coordination modes is computation of the so-called bond valence sum (BVS) (Brown and Altermatt 1985). The value of BVS is, in fact, expected to be approximately the formal oxidation number of the metal ion, i.e. 2 in our case. (BVS) is computed by use of the formula:

(BVS)=expr(0)rB, (8)

where the sum over ℓ extends over the contributions from all the metal ligands. The quantities r(0) and B are phenomenological variables depending on the nature of metal and ligands, and can be found in Thorp (1992). In our case Zn2+ is bound to four ligands, all at the same distance, which can be either O or N, according to the model we consider (column 2 of Table 3). Because r(0) and B for O and N are very similar, with rZnN(0)=1.72Å (Brown 2010), rZnO(0)=1.70Å, and BZn−OBZn−N (34), Eq. (8) can be usefully simplified to the form:

(BVS)in=4×expr¯(0)rinB (9)

with (0) the average value between rZnN(0) and rZnO(0). Indices i and n (with the meaning specified above) which have been appended to BVS as the actual Zn–ligand distances, 〈rin〉, depend both on the model and the sample. The BVS values computed according to Eq. (9) are given in the last column of Table 3.

Looking at the whole set of numbers reported in Table 3, the first striking observation is that in sample S3_Zn, the mean distance obtained from the |FT| data (column 3) is equal, within experimental error, to the first shell distance of Zn2+ in buffer (last row). This equality leads in turn to values of 〈r3n〉 that are perfectly consistent with the first shell distance of Zn2+ in buffer. We then conclude that in sample S3_Zn, Zn2+ is free in solution, and Eq. (6) loses its meaning, because in this case Zn2+ is expected to be coordinated by six ligands.

Information contained in BVS can be used to identify the range of “acceptable” values for the fraction, xin, of Zn2+ free in solution in each sample. For this purpose we exploit Eq. (9) to obtain the 〈rin〉 values corresponding to an acceptable BVS range of values for the Zn2+ oxidation number. A 10% error is normally attributed to a BVS calculation, thus leading to the acceptable interval (BVSmin = 1.8, BVSmax = 2.2). Inverting Eq. (9) leads to rmax = 2.01 Å and rmin = 1.93 Å . In Fig. 9rin〉 is plotted against xin, with the two horizontal lines drawn in correspondence to rmax and rmin.

Fig. 9.

Fig. 9

The three curves are obtained by plotting 〈rin〉 against xin as computed from Eq. (6) for S1_Zn (red), S2_Zn (blue), and S3_Zn (green). Full dots correspond to the values given in Table 3. Horizontal black lines are drawn in correspondence to the rmax and rmin values computed from Eq. (9). Vertical, red and blue lines are drawn from the point where each curve intersects the horizontal black lines, thus limiting the interval of acceptable xin values

Continuous lines are obtained from Eq. (6), whereas full dots indicate the xin values corresponding to the four Mn models. The vertical lines identify the region of “acceptable” xin values for sample S1_Zn (red) and S2_Zn (blue) according to our criteria. In particular xin is found to lie between 0.18 and 0.56 for sample S1_Zn and between 0.54 and 0.78 for sample S2_Zn. These findings are in agreement with the values (0.30 and 0.58, respectively) one obtains for xin by assuming that in both samples Zn is bound as in model M1 (Table 3). It should be noted, however, that for sample S2_Zn, the binding mode suggested in model M2 cannot be completely excluded.10

With regard to sample S3_Zn (green line), the BVS values are not informative, because, as we said above, the hypothesis of a fourfold coordination in Eq. (9) cannot be true if all Zn2+ is supposed to be in solution. On the other hand, assuming that in the buffer Zn is coordinated to six ligands, the very good value BVSbuffer = 2.2 ± 0.2 is obtained (last line of Table 3).

Discussion

In this paper we have shown that XAS measurements can be used to clarify the mechanism of Cu2+ affinity modulation induced by Zn2+ that was left open in Walter et al. (2007). We have found that Zn2+ modifies the Cu2+ coordination mode by directly interacting with the PrP peptide. This conclusion can be directly inferred from the fact that the XAS spectrum of sample S1_Zn is definitely different from that of Zn2+ in buffer (Figs. 4 and 5).

The most natural hypothesis of the way Zn2+ interacts with the peptide is to assume that it directly binds His units. In fact, EPR results have shown that the presence of Zn2+ promotes the partial switch of Cu2+ coordination mode from component β, in which the Cu2+ is bound to four His units, to component α, in which only one His is bound to Cu2+ (see Walter et al. 2007 and Fig. 1) suggesting that Zn2+ competes for His binding.

Under the assumption that this picture is correct, one can compute the number of His units involved in Zn2+ binding. Careful analysis based on XAS data and (BVS) calculation leads to the conclusion that the number of Zn2+ bound His units is most probably one and certainly no larger than two (Fig. 9 and Table 3).

The analysis presented in the paper confirms the important result of Walter et al. (2007) according to which Cu2+ is never completely removed by Zn2+. This finding suggests that the Cu-His binding strength depends on the number of His units already bound to Cu2+. Results in this direction are obtained by the numerical computation carried out by Guerrieri et al. (2009), in which the effect of Gly deprotonation is shown to be crucial in determining the metal coordination mode.

In Fig. 10 we show a sketch of the structural modifications induced by adding Zn. In the first reaction (upper line) that occurs at low Cu2+ concentration in which only the β component is present, Zn2+ binds one or two His units, displacing Cu2+. The second reaction (lower line) shows that when Cu2+ concentration is sufficiently high to have only the α component, Zn2+ is no longer able to remove Cu2+ and no longer interacts with the peptide, thus having only very limited effect on the Cu2+ coordination mode.

Fig. 10.

Fig. 10

Sketch of Zn2+ action at low (upper reaction) and high (lower reaction) Cu2+ concentration. The tetra-octa-repeat is drawn as a blue string. His units are shown explicitly. Green dot is Cu2+, red dot is Zn2+, and grey dots are water oxygens

We close with a comment concerning the interesting result reported by Walter et al. (2007), in which DEPC modification followed by mass spectroscopy was used to measure Zn2+ affinity for PrP peptides, spanning both the non-octa-repeat Cu2+ binding sites, PrP(90–114), and the octa-repeat region, PrP(60–91). Experiments have shown that, in the absence of Cu2+, Zn2+ only binds to the octa-repeat region with all four octa-repeats engaged in a stable Zn2+ to four-His units bonded configuration. The lack of Zn2+ binding to PrP peptides with fewer than four octa-repeats emerging in DEPC modification experiments may seem to contradict the result found here according to which, in the presence of Cu2+, a Zn2+ ion can be found to bind one His by partially displacing Cu2+. To reconcile simultaneous Cu2+ and Zn2+ uptake, Walter et al. (2007) proposed the coexistence in solution of two metal-bound PrP species: one with a single Zn2+ coordinated by four His residues and another in which each of the four available His units is bound to a Cu2+ ion. This picture, however, does not clarify the reason for the effect of Zn on the Cu coordination mode.

The results in this paper provide a rather different and simpler picture in which a single octa-repeat domain takes up both Cu2+ and Zn2+. Moreover, our findings suggest that Cu2+ may introduce a kink or local conformation that assists Zn2+ binding in a somewhat unusual 2-His coordination mode, as shown in Fig. 10. This kind of binding leads to a mechanism of cross-regulation between Cu2+ and Zn2+ that is worth further investigation in other biological systems (for example the Aβ-peptides involved in Alzheimer’s disease). This mechanism may, in fact, suggest the existence of an additional general strategy for fine regulation of metal binding to avoid cell damage.

Supplementary Material

Supplemental

Acknowledgments

We are very grateful to G.C. Rossi for useful discussions and for reading the manuscript. Partial financial support from PRIN08 is acknowledged. We thank the anonymous referees for their useful suggestions.

Footnotes

1

For a more detailed description of how the χ(k) EXAFS signal is extracted from XAS data see the Appendix in Minicozzi et al. (2008).

2

The normalization is performed in a standard way using the ATHENA software (Ravel 2008), i.e. fitting the pre-edge region with a straight line and subtracting it from the whole spectrum (Ravel and Newville 2005). The post-edge region data are then fitted with a polynomial. Finally, the jump between the pre-edge and the post-edge fits at the edge energy is calculated and the spectrum is divided by the height of the jump. We recall the standard formulae χ(k)=µ(E)µ0(E)µ0(E) and k=2m(EE0) where µ0(E) is the single atom absorption coefficient and E0 is the edge energy.

3

For completeness we provide in the supplementary material a quantitative analysis of the EXAFS spectra of samples S3 and S3_Zn data at the Cu K-edge. The analysis confirms that the structure of the Cu2+ binding site is not affected by the presence of Zn2+ and the fitted site geometry is highly consistent with the available crystallo-graphic information (Chattopadhyay et al. 2005).

4

It should be said that here we have simplified the analysis by assuming that component β corresponds to a situation in which all four His units of each tetra-octa-repeat are simultaneously involved in binding the metal. For the sake of completeness, the same analysis has also been performed assuming that Cu2+ in component β is bound to three His units. The results obtained under this assumption do not differ from those presented here in the text and can be found in the supplementary material.

5

The fraction of bound Cu2+ as a function of the Zn2+ concentration has been measured in Walter et al. (2007). As seen in Fig. 1 of that paper, the fraction of bound Cu2+ does not significantly depend on the concentration of Zn2+.

6

Here we make the further hypothesis that the reason why Zn2+ can be found free in solution it is that there are no more available His units.

7

The quality factor R is computed by use of the formula: R=i=1P1Wi|χexp(ki)χfit(ki)| where P is the number of experimental points and Wi=1kinj=1Pkjn|χexp(kj)| in which n is an integer which is normally taken to lie between 0 and 3 (here we took n = 3).

8

In all the fits only the distance and relative position of the nearest neighbouring atoms in the His-bound Zn2+ environment are taken as free variables.

9

Incidentally, we have also tried to leave the Zn2+ fraction in buffer as a free variable in the fit to the S1_Zn XAS spectra (data not shown). Values in good agreement with the numbers in the second column of Table 2 are obtained when the structural models M1 and/or M2 are assumed. Completely unrealistic values are instead selected by the fit with models M3 and M4.

10

In the supplementary material the same plot as in Fig. 9 is drawn by also taking into account the errors in the 〈rin〉 determination. In this way both M1 and M2 models yield numbers for 〈rin〉 that fall within the range of the acceptable BVS values as defined in the text.

Electronic supplementary material The online version of this article (doi:10.1007/s00249-011-0713-4) contains supplementary material, which is available to authorized users.

Contributor Information

Francesco Stellato, Dipartimento di Fisica, Università di Roma ‘Tor Vergata’, Via della Ricerca Scientifica, 1, 00133 Rome, Italy morante@roma2.infn.it; Centre for Free-Electron Laser Science, DESY, Notkestrasse 85, 22607 Hamburg, Germany.

Ann Spevacek, Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.

Olivier Proux, Observatoire des Sciences de l’Univers de Grenoble, CNRS and Université Joseph Fourier, BP 53, 38041 Grenoble Cedex 9, France.

Velia Minicozzi, Dipartimento di Fisica, Università di Roma ‘Tor Vergata’, Via della Ricerca Scientifica, 1, 00133 Rome, Italy morante@roma2.infn.it.

Glenn Millhauser, Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.

Silvia Morante, Dipartimento di Fisica, Università di Roma ‘Tor Vergata’, Via della Ricerca Scientifica, 1, 00133 Rome, Italy morante@roma2.infn.it.

References

  1. Aronoff-Spencer E, Burns CS, Avdievich NI, Gerfen GJ, Peisach J, Antholine WE, Ball HL, Cohen FE, Prusiner SB, Millhauser GL. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry. 2000;39:13760–13771. doi: 10.1021/bi001472t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Binsted N. EXCURV98. Warrington, Cheshire, UK: CCLRC Daresbury Laboratory; 1998. [Google Scholar]
  3. Binsted N, Strange RW, Hasnain SS. Constrained and restrained refinement in EXAFS data analysis with curved wave theory. Biochemistry. 1992;31:12117–12125. doi: 10.1021/bi00163a021. [DOI] [PubMed] [Google Scholar]
  4. Brown ID. Private communication. 2010 (see also www.mrl.ucsb.edu/~seshadri/2009_218/bvparm2006.pdf) [Google Scholar]
  5. Brown ID, Altermatt D. Bond-valence parameters obtained from a systematic analysis of the inorganic crystal structure database. Acta Cryst. 1985;B4:244–247. [Google Scholar]
  6. Burns CS, Aronoff-Spencer E, Dunham CM, Lario P, Avdievich NI, Antholine WE, Olmstead MM, Vrielink A, Gerfen GJ, Peisach J, Scott WG, Millhauser GL. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry. 2002;41:3991–4001. doi: 10.1021/bi011922x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burns CS, Aronoff-Spencer E, Legname G, Prusiner SB, Antholine WE, Gerfen GJ, Peisach G, Millhauser GL. Copper coordination in the full-length, recombinant prion protein. Biochemistry. 2003;42:6794–6803. doi: 10.1021/bi027138+. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cereghetti GM, Schweiger A, Glockshuber R, Van Doorslaer S. Electron paramagnetic resonance evidence for binding of Cu2+ to the C-terminal domain of the murine prion protein. Biophys J. 2001;81:516–525. doi: 10.1016/S0006-3495(01)75718-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chattopadhyay M, Walter ED, Newell DJ, Jackson PJ, Aronoff-Spencer E, Peisach J, Gerfen GJ, Bennett B, Antholine WE, Millhauser GL. The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4. J Am Chem Soc. 2005;127(36):12647–12656. doi: 10.1021/ja053254z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. D’Angelo P, Benfatto M, Della Longa S, Pavel NV. Combined XANES and EXAFS analysis of Co2+, Ni2+, and Zn2+ aqueous solutions. Phys Rev B. 2002a;66:064209. [Google Scholar]
  11. D’Angelo P, Barone V, Chillemi G, Sanna N, Meyer-Klaucke W, Pavel NV. Hydrogen and higher shell contributions in Zn2+, Ni2+, and Co2+ aqueous solutions: an X-ray absorption fine structure and molecular dynamics study. J Am Chem Soc. 2002b;124:1958–1967. doi: 10.1021/ja015685x. [DOI] [PubMed] [Google Scholar]
  12. Dominikus AL, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L, von Schroetter C, Fiorito F, Herrmann T, Güntert P, Wüthrich K. Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci USA. 2005;102:640–645. doi: 10.1073/pnas.0408937102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eghiaian F, Grosclaude J, Lesceu S, Debey P, Doublet B, Tréguer E, Rezaei H, Knossow M. Insight into the PrPC→PrP(SC) conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc Natl Acad Sci USA. 2004;101:10254–10259. doi: 10.1073/pnas.0400014101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ferreira GC, Franco R, Mangravita A, George GN. Unraveling the substrate-metal binding site of ferrochelatase: an X-ray absorption spectroscopic study. Biochemistry. 2002;41:4809–4818. doi: 10.1021/bi015814m. [DOI] [PubMed] [Google Scholar]
  15. Fonda L. Multiple-scattering theory of X-ray absorption: a review. J Phys Condens Matter. 1992;4:8269–8302. [Google Scholar]
  16. Gasset M, Baldwin MA, Fletterick RJ, Prusiner SB. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci USA. 1993;90:1–5. doi: 10.1073/pnas.90.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Guerrieri F, Minicozzi V, Morante S, Rossi GC, Furlan S, La Penna G. Modeling the interplay of glycine protonation and multiple histidine binding of copper in the prion protein octarepeat sub-domains. J Biol Inorg Chem. 2009;14:361–374. doi: 10.1007/s00775-008-0454-8. [DOI] [PubMed] [Google Scholar]
  18. Hasnain SS, Murphy LM, Strange RW, Grossmann JG, Clarke AR, Jackson GD, Collinge J. XAFS Study of the High-affinity Copper-binding Site of Human PrP91-231 and its low-resolution structure in solution. J Mol Biol. 2001;311:467–473. doi: 10.1006/jmbi.2001.4795. [DOI] [PubMed] [Google Scholar]
  19. Hornshaw MP, McDermott JR, Candy JM, Lakey JH. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun. 1995;214:993–999. doi: 10.1006/bbrc.1995.2384. [DOI] [PubMed] [Google Scholar]
  20. Minicozzi V, Stellato F, Comai M, Dalla Serra M, Potrich C, Meyer-Klaucke W, Morante S. Identifying the minimal Cu and Zn binding site sequence in amyloid beta peptides. J Biol Chem. 2008;283:10784–10792. doi: 10.1074/jbc.M707109200. [DOI] [PubMed] [Google Scholar]
  21. Morante S. Metal ions and protein aggregation: the case of prion protein and β-amyloids (invited review) In: Bulone D, San Biagio PL, editors. Biophysical inquiry into protein aggregation and amyloid diseases, research signpost edition. Kerala: Transworld Research Network; 2008. pp. 53–110. [Google Scholar]
  22. Morante S, González-Iglesias R, Potrich C, Meneghini C, Meyer-Klaucke W, Menestrina G, Gasset M. Inter- and intra-octarepeat Cu(II) site geometries in the prion protein. Implication in Cu(II) binding cooperativity and Cu(II)-mediated assemblies. J Biol Chem. 2004;279:11753–11759. doi: 10.1074/jbc.M312860200. [DOI] [PubMed] [Google Scholar]
  23. Nunziante M, Gilch S, Schatzl HM. Essential rôle of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein. J Biol Chem. 2003;278:3726–3734. doi: 10.1074/jbc.M206313200. [DOI] [PubMed] [Google Scholar]
  24. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB. Conversion of α-Helices β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA. 1993;90:10962–10966. doi: 10.1073/pnas.90.23.10962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Proux O, Biquard X, Lahera E, Menthonnex J-J, Prat A, Ulrich O, Soldo Y, Trévisson P, Kapoujvan G, Perroux G, Taunier P, Grand D, Jeantet P, Deleglise M, Roux J-P, Hazemann J-L. FAME: A new beamline for X-ray absorption investigations of very-diluted systems of environmental, material and biological interests. Phys Scripta. 2005;115:970–973. [Google Scholar]
  26. Proux O, Nassif V, Prat A, Ulrich O, Lahera E, Biquard X, Menthonnex J-J, Hazemann J-L. Feedback system of a liquid nitrogen cooled double-crystal monochromator: design and performances. J Synchrotron Radiat. 2006;13:59–68. doi: 10.1107/S0909049505037441. [DOI] [PubMed] [Google Scholar]
  27. Prusiner SB. Prions. Proc Natl Acad Sci USA. 1998;95:13363–13383. doi: 10.1073/pnas.95.23.13363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Qin K, Yang Y, Mastrangelo P, Westaway D. Mapping Cu(II) binding sites in prion proteins by diethyl pyrocarbonate modification and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometric footprinting. J Biol Chem. 2002;277:1981–1990. doi: 10.1074/jbc.M108744200. [DOI] [PubMed] [Google Scholar]
  29. Rachidi W, Mange A, Senator A, Guiraud P, Riondel J, Benboubetra M, Favier A, Lehmann S. Prion infection impairs copper binding of cultured cells. J Biol Chem. 2003;278:14595–14598. doi: 10.1074/jbc.C300092200. [DOI] [PubMed] [Google Scholar]
  30. Ravel B. ATHENA user’s guide. 2008 http://cars9.uchicago.edu/ravel/software/exafs/
  31. Ravel B, Newville M. ATHENA, ARTEMIS, HEPHAESTUS: data analysis for X-ray absorption spectroscopy using IFEFFIT. J Synchrotron Rad. 2005;12:537–541. doi: 10.1107/S0909049505012719. [DOI] [PubMed] [Google Scholar]
  32. Stockel J, Safar J, Wallace AC, Cohen FE, Prusiner SB. Prion protein selectively binds copper(II) ions. Biochemistry. 1998;37:7185–7193. doi: 10.1021/bi972827k. [DOI] [PubMed] [Google Scholar]
  33. Strange RW, Alagna L, Durham P, Hasnain SS. An understanding of the x-ray absorption near-edge structure of copper(II) imidazole complexes. J Am Chem Soc. 1990;112:4265–4268. [Google Scholar]
  34. Thorp HH. Bond valence sum analysis of metal-ligand bond lengths in metalloenzymes and model complexes. Inorg Chem. 1992;31:1585–1588. [Google Scholar]
  35. Walter ED, Stevens DJ, Visconte MP, Millhauser GL. The prion protein is a combined zinc and copper binding protein: Zn2+ alters the distribution of Cu2+ coordination modes. J Am Chem Soc. 2007;129:15440–15441. doi: 10.1021/ja077146j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wells MA, Jelinska C, Hosszu LLP, Craven CJ, Clarke AR, Collinge J, Waltho JP, Jackson GS. Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. Biochem J. 2006;400:501–510. doi: 10.1042/BJ20060721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Whittal RM, Ball HL, Cohen FE, Burlingame AL, Prusiner SB, Baldwin MA. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci. 2000;9:332–343. doi: 10.1110/ps.9.2.332. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental

RESOURCES